If I Took It Out Today, Would an Outcome Change? | The 229 Podcast with Diane Constantine, Cathy Patterson, and Vicki Sergent
Apple Podcasts
Questions Answered in This Episode
- If an innovation cannot produce a 12-month ROI, does it still deserve to scale?
- If I took it out today, would an outcome change?
- Who owns the outcome after go-live?
- Is adoption without outcome just vanity?
- What is on your scorecard that would fail Cathy Patterson's test?
About This Episode
September 3, 2026: Diane Constantine (Children's Hospital of Philadelphia), Cathy Patterson (Banner Health), and Vicki Sergent (Froedtert ThedaCare Health) sit down with Sarah Richardson. If an innovation saves clinician time, prevents harm, and improves the patient experience, but cannot produce a clean 12-month ROI, does it deserve to scale? Cathy's test: if she took it out today, would an outcome change. Vicki's MyChart Bedside was supposed to take a year of phased rollouts. Innovation-unit nurses adopted it hard enough that the system was up in three months. Diane will not manufacture a dollar value for rare pediatric harm. She will measure it.
Key Points:
0:00 Does a 12-month ROI decide scale
1:30 Name the scorecard
6:10 UST
6:43 Set the thresholds before go-live
11:20 Value that never hits the P&L
16:19 Who owns the outcome after go-live
21:04 Adoption versus vanity
25:58 One decision they would copy
31:31 The question for tomorrow's scorecard
Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer
Thank You to Our Episode Partner
Contributors
People featured in this episode — open a profile for more.
